Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-47.11M
↑ 21% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-59.76M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-47.11M | -133.3% |
| 2024 | $-20.20M | +74.6% |
| 2023 | $-79.63M | -16.8% |
| 2022 | $-68.17M | -30.0% |
| 2021 | $-52.44M | -34.2% |
| 2020 | $-39.09M | +60.1% |
| 2019 | $-98.06M | +4.0% |
| 2018 | $-102.17M | -82.8% |
| 2017 | $-55.90M | -60.5% |
| 2016 | $-34.84M | - |